DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 04 · Volume 32 · June 2006 DOI: 10.1055/s-002-4999 Part 2: Essential Thrombocythemia and Polycythemia Vera: Diagnosis, Pathophysiology, and Management Jan J Michiels M.D. Ph.D. Martin Griesshammer M.D. Ph.D.

PREFACE

  • 305
    Mammen, Eberhard F.:

    Part 2: Essential Thrombocythemia and Polycythemia Vera

  • 307
    Michiels, Jan J.; Raeve, Hendrik De; Berneman, Zwi; Bockstaele, Dirk Van; Hebeda, Konnie; Lam, King; Schroyens, Wilfried:

    The 2001 World Health Organization and Updated European Clinical and Pathological Criteria for the Diagnosis, Classification, and Staging of the Philadelphia Chromosome-Negative Chronic Myeloproliferative Disorders

  • 341
    Villeval, Jean-Luc; James, Chloé; Pisani, Didier F.; Casadevall, Nicole; Vainchenker, William:

    New Insights into the Pathogenesis of JAK2 V617F-Positive Myeloproliferative Disorders and Consequences for the Management of Patients

  • 352
    Thiele, Juergen; Kvasnicka, Hans Michael; Schmitt-Graeff, Annette:

    Effects of Anagrelide on Megakaryopoiesis and Platelet Production

  • 362
    Kvasnicka, Hans Michael; Thiele, Juergen:

    The Impact of Clinicopathological Studies on Staging and Survival in Essential Thrombocythemia, Chronic Idiopathic Myelofibrosis, and Polycythemia Rubra Vera

  • 372
    Griesshammer, Martin:

    Risk Factors for Thrombosis and Bleeding and Their Influence on Therapeutic Decisions in Patients with Essential Thrombocythemia

  • 381
    Bellucci, Sylvia; Michiels, Jan J.:

    The Role of JAK2 V617F Mutation, Spontaneous Erythropoiesis and Megakaryocytopoiesis, Hypersensitive Platelets, Activated Leukocytes, and Endothelial Cells in the Etiology of Thrombotic Manifestations in Polycythemia Vera and Essential Thrombocythemia

  • 399
    Petrides, Petro E.:

    Anagrelide: What Was New in 2004 and 2005?

  • 409
    Quintás-Cardama, Alfonso; Kantarjian, Hagop M.; Giles, Francis; Verstovsek, Srdan:

    Pegylated Interferon Therapy for Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders

  • 417
    Kiladjian, Jean-Jacques; Rain, Jean-Didier; Bernard, Jean-Francois; Briere, Jean; Chomienne, Christine; Fenaux, Pierre:

    Long-Term Incidence of Hematological Evolution in Three French Prospective Studies of Hydroxyurea and Pipobroman in Polycythemia Vera and Essential Thrombocythemia

  • 422
    Griesshammer, Martin; Struve, Sabine; Harrison, Claire M.:

    Essential Thrombocythemia/Polycythemia Vera and Pregnancy: The Need for an Observational Study in Europe

  • 430
    Gisslinger, Heinz:

    Update on Diagnosis and Management of Essential Thrombocythemia

  • 437
    Silver, Richard T.:

    Treatment of Polycythemia Vera